Effect of <i>HLA-DRB1</i> alleles and genetic variants on the development of neutralizing antibodies to interferon beta in the BEYOND and BENEFIT trials — Dorothea Buck (2018) | RDL Network
Effect of <i>HLA-DRB1</i> alleles and genetic variants on the development of neutralizing antibodies to interferon beta in the BEYOND and BENEFIT trials
Article 2018 en
Authors
DB
Dorothea Buck
TA
Till F. M. Andlauer
WI
Wilmar Igl
Abstract
1 min read
The contribution of HLA alleles and HLA-associated single-nucleotide polymorphisms (SNPs) to the development and titer of antibodies against interferon β was confirmed in the combined analysis of two multi-national, multi-center studies.
Nabila Bouatia‐Naji, Amélie Bonnefond, Devin A. Baerenwald, Marion Marchand, Marco Bugliani, Piero Marchetti, François Pattou, Richard L. Printz, Brian P. Flemming, Obi C. Umunakwe, Nicholas L. Conley, Martine Vaxillaire, Olivier Lantieri, Beverley Balkau, Michel Marre, Claire Lévy‐Marchal, Paul Elliott, Paul M Ridker, Stephen Eyre, Christian Dina, James K. Oeser,
Yonghong Li, Irene D. Bezemer, Charles M. Rowland, Carmen H. Tong, André R. Arellano, Joseph J. Catanese, James J. Devlin, Pieter H. Reitsma, Lance A. Bare, Frits R. Rosendaal
Discussion(0)
No comments yet. Be the first to comment.